封面
市場調查報告書
商品編碼
2052837

非侵入性血糖監測設備市場:按技術、測量方法、最終用戶和地區分類。

Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,非侵入性血糖監測設備市場規模將達2,820萬美元,到2033年將達到8,020萬美元。預計從2026年到2033年,該市場將以16.1%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 2820萬美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 16.10% 2033年市場規模預測: 8020萬美元

顧名思義,非侵入性血糖監測是指在不損傷人體組織的情況下測量血糖值。與傳統的指尖採血方法相比,非侵入性血糖監測設備提供了一種更經濟、更無痛的血糖值測量方法。這些設備的工作原理是掃描皮膚附近的血管,而不是抽取血液。微創微針、近紅外線光譜和超寬頻雷達等血糖感測技術的進步,使得開發出能夠獲得與有創監測方法非常接近的非侵入性產品成為可能。這使得糖尿病患者在管理自身病情時更加方便,也更容易堅持下去。根據技術的不同,非侵入性血糖監測設備可分為電磁式、經皮、光學式和酵素式等類型。

市場動態

全球糖尿病患者數量的不斷成長以及連續血糖監測技術的進步推動了非侵入性血糖監測設備市場的發展。許多新參與企業正攜創新解決方案進軍市場,試圖克服現有侵入性檢測方法(例如指尖採血)的種種挑戰。然而,與標準方法相比,非侵入性血糖監測在提高準確性方面仍存在技術局限性,臨床檢驗不足,以及監管核准延遲等問題,這些因素仍然阻礙其廣泛應用。儘管如此,持續不斷的研發工作,尤其是致力於改進演算法和感測器的研發,正為非侵入性血糖監測解決方案成為傳統血糖檢測的切實替代方案創造著充滿希望的機會。

預計在預測期內,知識匱乏和診斷延遲將阻礙全球非侵入性血糖監測設備市場的成長。

本次調查的主要特點

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數創建了全球非侵入性血糖監測設備市場主要公司的概況:公司亮點、產品系列、主要特點、財務表現和策略。
  • 本研究涵蓋的主要公司包括 Baxter International、Dexcom、Abbott、Medtronic、 Medtronic Holdings、GlySens Incorporated、DiaMonTech GmbH、Nemaura Medical Inc.、Integrity Applications, Inc.、CNOGA Medical Ltd.、Breath Health, Inc.、Metamaterial Technologies Inc.、Opticology Inc.S.
  • 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球無創血糖值監測設備市場報告」旨在為該行業的各種相關人員提供服務,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過對全球無創血糖監測設備市場進行分析時所使用的各種策略矩陣,相關人員將能夠更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
      • 需要使用新斯的明治療的疾病(如重症肌無力和術後腸阻塞)的盛行率增加。
    • 抑制因子
      • 缺乏知識和診斷
    • 機會
      • 獸醫學的發展
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章:全球非侵入性血糖監測設備市場:依技術分類,2021-2033年

  • EM Waves
  • 經皮型
  • 光學的
  • 酵素法

第5章:全球非侵入性血糖監測設備市場:依監測方式分類,2021-2033年

  • 穿戴式裝置
  • 非穿戴式/桌面型
  • 嵌入式裝置

第6章:全球非侵入性血糖監測設備市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診所
  • 居家醫療環境

第7章 全球非侵入性血糖監測設備市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • GCC
    • 以色列
    • 其他中東國家
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • Baxter International Inc.
  • Dexcom, Inc
  • Abbott
  • Medtronic
  • Senseonics Holdings, Inc
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI1480

Non-Invasive Blood Glucose Monitoring Devices Market is estimated to be valued at USD 28.2 Mn in 2026 and is expected to reach USD 80.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 28.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 16.10% 2033 Value Projection: USD 80.2 Mn

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Market Segmentation

  • Technology Insights (Revenue, USD Mn, 2021 - 2033)
  • EM Waves
  • Transdermal
  • Optical
  • Enzymatic
  • Modality Insights (Revenue, USD Mn, 2021 - 2033)
  • Wearable
  • Non-wearable/Benchtop
  • Embedded Devices
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Clinics
  • Homecare setting
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Baxter International Inc.
  • Dexcom, Inc.
  • Abbott Laboratories
  • Medtronic Plc
  • Senseonics Holdings, Inc.
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd.
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Modality
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
      • Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
    • Restraints
      • Lack of knowledge and diagnosis
    • Opportunities
      • The growth of veterinary medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • EM Waves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Enzymatic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Wearable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Non-wearable/Benchtop
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Embedded Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Homecare setting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2021 - 2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2021 - 2033,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Senseonics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlySens Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaMonTech GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nemaura Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integrity Applications, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CNOGA Medical Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Breath Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Metamaterial Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Opticology Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • NovioSense BV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quick LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • RSP Systems A/S.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us